Wells Fargo & Company Valneva Se Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Valneva Se stock. As of the latest transaction made, Wells Fargo & Company holds 246,766 shares of VALN stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
246,766
Previous 215,907
14.29%
Holding current value
$2.06 Million
Previous $1.3 Million
17.33%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VALN
# of Institutions
11Shares Held
620KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.95 Million0.15% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$208,4330.06% of portfolio
-
Abc Arbitrage Sa Paris, I019.2KShares$160,3020.01% of portfolio
-
Morgan Stanley New York, NY3.56KShares$29,6210.0% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD1KShares$8,3300.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $576M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...